TENT5C and colon adenocarcinoma: Consequently, low FAM46C expression was observed in eight tumours: bladder uroepithelial carcinoma (BLCA), colon adenocarcinoma (COAD), oesophageal cancer (ESCA), kidney chromophobe (KICH), prostate adenocarcinoma (PRAD), rectal adenocarcinoma (READ), stomach adenocarcinoma (STAD) and thyroid carcinoma (THCA) (Figure 1B).